Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bristol-Myers Squibb Company
Bristol-Myers Squibb Announces Filing of IPO Registration Statement for Mead Johnson Nutrition Company
October 4th, 2008
Bristol-Myers Squibb Company (NYSE:BMY) announced that its wholly-owned subsidiary, Mead Johnson Nutrition Company, has filed a registration statement with the U.S. Securities and Exchange Commission for an initial public offering ("IPO") of its Class A common stock. In April 2008, Bristol-Myers Squibb Company announced it would file a registration statement by the end of 2008 to sell approximately 10 percent and no more than 20 percent of Mead Johnson Nutrition Company stock to the public through an IPO. Bristol-Myers Squibb intends to retain at least an 80 percent equity interest in Mead Johnson Nutrition Company for the foreseeable future. The IPO process is expected...
Source: Law & Health Weekly (2008-10-04)
|
